CIK 0001951222 · Non-accelerated filer<br>Emerging growth company
SEALSQ Corp
Sign in to watch- Ticker
- LAES
- Exchange
- Nasdaq
- Industry
- Semiconductors & Related Devices
- FY end
- Dec 31
- Incorporated
- Virgin Islands, British
- Entity type
- other
- Phone
- 212-336-2039
- Business address
- AVENUE LOUIS-CASAI 58, COINTRIN, Switzerland, 1216
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $170,294
- in 3 filings, $170K under 10b5-1 plans
Net −$170,294. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-03 | Enguent Jean-Pierre Vice President, R&DSS | Sale 10b5-1 | −35,000 | $1.38 | $48K | 0 |
| 2026-11-02 | Enguent Jean-Pierre Vice President, R&DSS | Option exercise 10b5-1 | +15,000 | $0.01 | $150 | 15,000 |
| 2026-11-02 | Enguent Jean-Pierre Vice President, R&DSS | Option exercise 10b5-1 | +20,000 | $0.01 | $200 | 35,000 |
| 2026-11-02 | Enguent Jean-Pierre Vice President, R&DSS | Option exercise · Employee Stock Option Plan (right to buy) 10b5-1 | −15,000 | 0 | ||
| 2026-11-02 | Enguent Jean-Pierre Vice President, R&DSS | Grant or award · Employee Stock Option Plan (right to buy) 10b5-1 | +50,000 | 50,000 | ||
| 2026-11-02 | Enguent Jean-Pierre Vice President, R&DSS | Option exercise · Employee Stock Option Plan (right to buy) 10b5-1 | −20,000 | 30,000 | ||
| 2026-10-06 | Enguent Jean-Pierre Vice President, R&DSS | Sale 10b5-1 | −35,000 | $2.46 | $86K | 0 |
| 2026-10-05 | Enguent Jean-Pierre Vice President, R&DSS | Option exercise 10b5-1 | +35,000 | $0.01 | $350 | 35,000 |
| 2026-10-05 | Enguent Jean-Pierre Vice President, R&DSS | Grant or award · Employee Stock Option Plan (right to buy) 10b5-1 | +50,000 | 50,000 | ||
| 2026-10-05 | Enguent Jean-Pierre Vice President, R&DSS | Option exercise · Employee Stock Option Plan (right to buy) 10b5-1 | −35,000 | 15,000 | ||
| 2026-10-05 | Ward Peter Director | Grant or award · Employee Stock Option Plan (right to buy) | +3,582 | 3,582 | ||
| 2026-10-05 | Ward Peter Director | Grant or award · Employee Stock Option Plan (right to buy) | +4,686 | 4,686 | ||
| 2026-09-25 | Fergusson David Alexander Director | Grant or award · Employee Stock Option Plan (right to buy) | +3,424 | 3,424 | ||
| 2026-09-25 | Fergusson David Alexander Director | Grant or award · Employee Stock Option Plan (right to buy) | +14,063 | 14,063 | ||
| 2026-09-25 | Pellaton Eric Adrien Director | Grant or award · Employee Stock Option Plan (right to buy) | +10,747 | 10,747 | ||
| 2026-09-25 | Pellaton Eric Adrien Director | Grant or award · Employee Stock Option Plan (right to buy) | +14,063 | 14,063 | ||
| 2026-09-03 | Enguent Jean-Pierre Vice President, R&DSS | Sale 10b5-1 | −15,000 | $2.40 | $36K | 0 |
| 2026-09-01 | Enguent Jean-Pierre Vice President, R&DSS | Option exercise 10b5-1 | +15,000 | $0.01 | $150 | 15,000 |
| 2026-09-01 | Enguent Jean-Pierre Vice President, R&DSS | Option exercise · Employee Stock Option Plan (right to buy) 10b5-1 | −15,000 | 0 | ||
| 2026-08-05 | Enguent Jean-Pierre Vice President, R&DSS | Sale 10b5-1 | −15,000 | $2.46 | $37K | 0 |
Page 1 of 5 · 82 trades